Abstract: Solid organ transplantation is the criterion standard treatment for many with end-organ failure and can offer a new independence from the burden of disease. However solid organ transplant recipients (SOTRs) remain at high risk of cardiovascular (CV) disease, and poor quality of life and physical functioning. Increasing physical activity and exercise can improve the health of the general population; however, the effects on those with a transplant remain unclear. Intensive exercise and sporting activity has the potential to be beneficial, although there remain concerns particularly around the effects on immune function and the CV system. This review summarizes what is known about the effects of exercise on determinants of health in SOTRs and then collates the available literature investigating the consequences of intensive exercise and sport on the health of SOTR. There is a paucity of high-quality research, with most evidence being case studies or anecdotal; this is understandable given the relatively few numbers of SOTRs who are performing sport and exercise at a high level. However, if suitable evidence-based guidelines are to be formed and SOTRs are to be given reassurances that their activity levels are not detrimental to their transplanted organ and overall health, then more high-quality studies are required.
S
olid organ transplantation offers those with end-stage organ disease an intervention that can transform their lives and is now the criterion standard of care. More patients are successfully undergoing transplants, partly owing to advances in surgical techniques, as well as improvements in donor recruitment, organ preservation, and immunosuppressive therapies. In the UK there has been a 12% increase in kidney transplants and a rise of 20% from donors after circulatory death. 1 Worldwide, there has been a steady increase in solid organ transplants (SOT) with 114,690 estimated to have taken place in 2012; however, this is meeting less than 10% of global need, meaning there is increased emphasis on improving transplant survival. 2 Morbidity and mortality after SOT continue to fall, and 1-year patient and graft survival from cadaveric transplants has increased over the past 10 years. 3 Therefore, the long-term focus is on identifying modifiable risk factors that can be addressed to improve health-related quality of life (HRQoL), morbidity, and survival.
Exercise has a range of health benefits to the general population including improved HRQoL, reduced cardiovascular (CV) risk, and chronic inflammation. However, there are many other factors that need consideration such as the effects of immunosuppression, their underlying disease process and altered body composition, which means that the effects of exercise in the general population cannot be directly translated into solid organ transplant recipients (SOTRs). In addition, many SOTRs wish to either return to, or begin, new sporting activities to improve their health after transplant, and this higher intensity exercise may have more unanticipated effects than activity at lower levels.
Competitive Events
The first Transplant Games were held in the UK in 1978 4 with 99 participants from 5 countries. Since then, there has been a significant growth in the event with emerging evidence of the benefit of exercise in SOTRs and the publicity surrounding the Games. There are a number of reasons why SOTRs take up sporting activities or exercise, ranging from perceived health benefits to enjoyment. It can be done simply as a hobby or for social reasons, but it can also be life affirming, a celebration of regained health or a way of showing appreciation to their donor and the health services.
The US Transplant Games attracts high-level athletes from across the country who have near age-predicted cardiorespiratory fitness and HRQoL. 5 Those more active participants have higher VO 2peak and lower body fat compared to those who train less intensely. [6] [7] [8] In a pediatric population, participation at the World Transplant Games (WTG) results in an improvement in habitual activity, with an increase in those achieving healthy CV fitness, abdominal strength, and upper body strength compared to controls who do not take part. 9 The location of the WTG has been shown to affect rates of organ donation in that local area. 10 Education, awareness, and engaging the public through the media have all been shown to increase knowledge of transplantation and affect willingness to donate. However, donation rates are rarely maintained after media coverage ceases.
These highly organized events have the potential to greatly improve our knowledge of the effects of high-intensity exercise on SOTRs and are a potential platform for the development of future research studies. This review article will summarize the current available literature examining the effects of physical activity and exercise on SOTRs.
SOLID ORGAN TRANSPLANTATION
Patients with chronic kidney disease and those on dialysis in particular have an elevated CV risk compared to the general population. [11] [12] [13] Kidney transplantation improves survival 14 and quality of life 15, 16 and reduces CV events 17, 18 compared to individuals on dialysis, although outcomes still remain poorer than in the general population, 19 with the rate of cardiac death 10 times higher and the annual rate of fatal or nonfatal CV events 50 times that of the general population. It is thought that this is due to traditional CV risk factors, which remain, such as hypertension and dyslipidemia, but nontraditional risks such as immunosuppression, [20] [21] [22] chronic inflammation, 23, 24 and altered hemostasis [25] [26] [27] also play an important role. Patients with severe heart failure, understandably, have elevated morbidity and mortality compared to the general population. The most common causes of death include congestive cardiac failure and arrhythmias. 28 However, these numbers have been improving, in part owing to the use of left ventricular assist devices, which act to delay or prevent the progression to end-organ failure. 29 Overall outcomes remain better after heart transplant than left ventricular assist devices, so this still remains the optimum treatment for those with end-stage heart failure. 30 After a heart transplant, patients have an improvement in survival, QoL, and exercise capacity, although these measures often do not reach those of their nontransplanted counterparts.
Heart transplant recipients (HTRs) represent a complex population, with several issues needing to be considered when determining their exercise capabilities. 31 Before transplantation, the donor heart experiences a significant ischemic time and then subsequently undergoes reperfusion when successfully transplanted into the recipient. Additionally, the anatomy is not completely restored and during the operation, the heart is surgically denervated, and this is not entirely corrected. In the postoperative months, some patients demonstrate signs of partial cardiac reinnervation, which may serve to, in part, normalize their responses to exercise. Heart transplant recipients also often experience diastolic dysfunction. The underlying causes are likely to be multifactorial including hypertension, episodes of rejection, and vasculopathy of the allograft. These factors directly affect the function of the transplant and are likely to influence the response to exercise.
For patients with chronic lung conditions, transplantation offers the chance of improving QoL, morbidity, and mortality. In the United States, there are 1572 people currently waiting for a transplant, with the most common underlying diagnoses being congenital disease, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. 32 Lung transplantation is a highly complex procedure that carries considerable perioperative and postoperative risks. It is a treatment option for patients whose pulmonary function, exercise capacity, and QoL are drastically restricted, and predicted 5-year survival is less than 50%. 33 There are 3 types of lung transplant: single lung transplantation (SLTx), double lung transplantation (DLTx), and simultaneous heart and lung transplantation (HLTx), with the selection depending on the underlying pathology. 34 The 1-and 5-year survival rates for SLTxRs and DLTxRs are 77% and 59%, respectively. 35 Infection (38%), rejection (29%), malignancy (15%), and cardiovascular disease (CVD) (10.9%) are the main contributors to morbidity and mortality postoperatively 33 as well as organspecific complications such as obliterative bronchiolitis, all of which may be influenced by physical activity. Posttransplant rehabilitation has recently been the focus, to optimize longterm outcomes and promote physical and psychological measures, as these still remain impaired despite transplantation, 36 with most lung transplant recipients (LTxRs) remaining sedentary 3 to 6 months after transplant. 37 Liver transplantation (LivTx) offers those with end-stage liver disease improved morbidity and mortality and is now an established procedure in the developed world, with more than 6000 transplants being performed in the United States in 2010. 38 Obesity and the development of metabolic syndrome are well recognized after LivTx, with an increasing body mass index (BMI) seen in the first few years after surgery and 22% of previously normal-weight individuals becoming obese within 2 years. 39 Independent predictors of obesity include episodes of acute rejection and a higher dose of prednisolone. In LivTx recipients (LivTxR), increased BMI at 1 year accurately predicts the development of metabolic syndrome, 40 and onethird will have CVD at 8 years. Therefore, addressing weight gain in the early postoperative period should be seen as a priority to reduce CVD in the future. Liver transplantation has also been shown to improve markers of QoL including selfreported physical health, daily activities, general HRQoL, and social functioning. 41 
CARDIOVASCULAR SYSTEM
Regular exercise has positive effects on CV risk in the general population, 42 and now, the focus has switched to analyzing the effect on transplant recipients.
Renal transplant recipients (RTRs) spontaneously increase their activity levels after transplantation, and this peaks at 1 year despite an initial decrease in the first month postoperatively, 43 whereas in the first 3 months after receiving a heart transplant, HTRs significantly increase their physical activity levels 44 although the effect plateaus after this time. Those transplant recipients who are more physically active have reduced CV risk, 45 and this principal has been used in the design of exercise programs aiming to improve a variety of physiological parameters.
Blood Pressure
In RTRs, there are no overall significant effects of exercise on blood pressure (BP) 46, 47 with both a supervised 6-week aerobic training and a 1-year home-based aerobic program yielding insignificant results in those undergoing the intervention (133/87 at baseline to 132/89 at 12 months) compared to the control group receiving usual care (138/88 to 133/90). Additionally, exercise programs for RTRs do not seem to interact with antihypertensive medications either, 48 with the number of antihypertensives being similar at all time-points and between groups.
In HTRs, exercise has been shown to have equivocal effects on BP. Some studies of supervised moderate intensity exercise for 10 to 12 weeks demonstrate little effect on either systolic or diastolic BP 49, 50 even when combined with strength training, 51 with the timing of commencement of the exercise program after transplantation not influencing outcomes. However, high-intensity interval training (HIIT) regimes (16-minute interval training with intervals of 4-, 2-, and 1-min duration at greater than 80% of VO 2peak , separated by a 2-minute active rest period) of 12-weeks duration, commenced more than 12 months after surgery, significantly reduce systolic BP compared to a control group of exercisers who continue to do moderateintensity activity. 50 Additionally, one 6-month study of cyclebased moderate intensity exercise 5 times a week at home, reduced both systolic and diastolic BP in the exercisers (143/78 at baseline to 121/69 at 6 months) compared to nonexercising controls (140/77 to 136/77), perhaps suggesting that a longer duration of intervention may be needed to have an effect. 52 Hypertension is common in HTRs, and betablockers have been shown to have an adverse effect on peak heart rate (HR) during exercise and overall exercise capability 53 ; therefore, their use needs to be carefully considered in active HTRs.
In LTxRs, a randomized control trial (RCT) of 3 months of 3 times-a-week combined aerobic and resistance training 54 led to a significant improvement in ambulatory 24-hour BP in the intervention group compared to controls. The exercising group maintained their BP at 1 year after transplantation (129/80 before transplant and 126/80 at 1 year), whereas the control group experienced worsening hypertension (126/73 to 142/89; P < 0.01).
Serum Cholesterol
In RTRs, there is no clear consensus as to whether exercise has a beneficial effect on lipid levels, as some studies show an improvement 55 and others do not. 47, [56] [57] [58] The only study to show an improvement in total serum cholesterol was based on a Chinese alternative therapy (Don Jeon) for a duration of 9 weeks with 1 once-a-week supervised session and daily activity at home. Unfortunately, the control group of transplanted patients was not equivalent, and therefore, it is difficult to draw a meaningful conclusion. The studies that showed no significant improvements in cholesterol profiles included a variety of interventions including combined exercise program and dietary advice, 56 supervised, 57 and home-based exercise. 47, 58 Additionally, there were also variations in type of exercise, with some being solely aerobic 47, 56 and others including only strengthening 57 or a combination of both. 58 Interestingly, in one study, 57 there was a significant increase in total cholesterol in both the exercise group (5.55-6.92 mmol/L at 5 weeks; P = 0.001) and the controls (5.40-6.85 mmol/L), although this is in part due to a rise in high-density lipoprotein (HDL)-cholesterol (1.29-1.67 mmol/L in exercisers vs 1.42 mmol/L to 1.51 mmol/L in controls; P = 0.05). There was no change seen in triglyceride levels.
In LTxRs, the RCT of combined aerobic and resistance training revealed no significant improvements in total cholesterol (219-191 mg/dL at 1 year) compared to controls (169-190 mg/dL) or triglycerides (107-159 mg/dL vs 86-145 mg/dL). 54 After LivTx, there is an increase in prevalence of hypertriglyceridemia and hypercholesterolemia after 1 year, 59 and metabolic syndrome is very common and has been described in 44% to 58% of patients 6 months after transplantation. 60 The development of metabolic syndrome is associated with lower exercise intensity and older age. In addition, exercise intensity is inversely related to the development of metabolic syndrome after LivTx, suggesting that those who are more active are likely to have improved CV risk factors. 61 However, an uncontrolled, supervised 12-week combined aerobic and strength training program with lifestyle counseling 62 found that there was actually no improvement in lipid profile with total cholesterol:HDL cholesterol ratio (3.70-3.74 after 12 weeks) and LDL cholesterol:HDL cholesterol ratio (2.08-2.09) remaining static.
Glycemic Control
In RTRs, the total amount of physical activity is significantly lower in RTRs with impaired glucose tolerance compared to RTRs with normal glucose tolerance (255 vs 580 minutes/wk, respectively; P = 0.03) and total physical activity has been identified as an independent predictor of impaired glucose tolerance in all RTRs (P = 0.04).
63 A 6-month study of combined lifestyle modification advice and 2-hour endurance exercise per week in RTRs 56 with either new-onset diabetes after transplant (NODAT) or impaired glucose tolerance (IGT) (group 1) versus RTRs with normal glucose tolerance receiving usual care (group 2) revealed a 15% improvement in 2-hour postprandial glucose in group 1 versus 12% deterioration in group 2 (P = 0.001). Additionally, in group 1, 44% of impaired glucose tolerance patients developed normal glucose tolerance, whereas only 4% developed NODAT, and 58% of NODAT patients showed improvement (29% to IGT and 29% to normal). Glucose metabolism deteriorated in group 2 with 14% developing IGT and 3% developing NODAT. Another study of strengthening exercise alone, 57 commenced within the first few days after transplantation, showed improvements in glucose levels in both the intervention group (102-83 mg/dL at the end of the study) and the control group (108-83 mg/dL), which may reflect changes in medications (such as decreased steroid doses).
Three months of 3 times-a-week aerobic and resistance training in LTxRs 54 leads to a trend of reduced rates of overall progression to NODAT (6%) compared to the control group (25%), although this is not significant (P = 0.11) and also a reduction in fasting glucose (99-90 mg/dL at 1 year vs 88-107 mg/dL), but again, this is not significant (P = 0.13). However, in LivTxRs, after a 12-week aerobic and strength exercise program, there was actually a trend toward worsening of glycemic control (HbA1c, 5.40% to 5.60% after the program; P = 0.071).
62

BODY COMPOSITION Body Weight and Soft Tissue
Observational studies have shown that those RTRs who are more physically active have lower amounts of body fat 64 ; however, a randomized trial of home-based cardiovascular exercise versus usual care has shown particularly disappointing effects on body composition. 48 In fact, body weight and BMI increase in both groups from baseline (intervention: 24. ; P = 0.005), although there were nonsignificant changes in both total fat area and overall thigh area.
Previous congestive cardiac failure and reduced pretransplantation physical activity both contribute to deterioration in overall body composition. In HTRs, a 12-week combined aerobic and strength training program increased total lean tissue mass compared to the control group, 51 and 6 months of resistance exercise training alone also had positive results compared to the control group. 67 Fat mass significantly increased at 2 months after transplant in both the control (+8.3%) and exercising groups (+7.3%) and 6 months of resistance training restored fat-free mass to levels 3.9% greater than before transplant (P < 0.05). Fat-free mass of the control group decreased progressively to levels that were 7% lower than pretransplant values (P < 0.05). However, HIIT programs have yet to be proven to be effective in improving body composition, 68 with no significant reduction in BMI in the intervention group (27.2-26.5 at follow-up) compared to the controls (26.3-26.3; P = 0.106) or improvement in body fat percentage (intervention: 26.1% to 25.2% at follow-up versus control: 24.6% to 25.0%; P = 0.152).
In LTxRs, a randomized trial of combined aerobic and resistance training 54 did not reveal any positive effects on body weight or BMI in either the intervention group (22.6-24.4 at 1-year) or the controls (21.5-24.1, P = 0.89), with both overall body weight and BMI increasing over time in both groups. A randomized 10-month home-based aerobic exercise program in combination with dietary advice has been shown to improve lean body mass, although coincidentally, there were also increases in body weight, fat-mass, and percentage of body fat. 69 Additionally, there were issues with adherence to the program, with only 37% following the program as instructed. When this was taken into account, total body weight, lean mass, and fat mass increased in all patients over the study period (P < 0.001), with no significant interactions found between the intervention and control groups in any of the body composition variables.
In LivTxRs, a randomized 24-week combined resistance and aerobic-based regime based either at home or supervised in a clinical setting, 70 resulted in a significant increase in BMI in the supervised exercise group compared to the homebased group and the controls (supervised: 20.4-24.4; homebased: 22.3-22.6; control: 22.2-22.2; P = 0.005). This increase was predominantly due to an increase in lean mass in the exercising groups (supervised: 43.4-48.9 kg; home-based: 41.7-47.0 kg; control: 49.9-45.1 kg; P = 0.009), with a nonsignificant change in fat mass (supervised: 13.9-17.5 kg; home-based: 16.4-15.6 kg; control: 13.2-15.1 kg; P > 0.05). However, in another study, 62 a 3-month combined training in a supervised group setting resulted in stabilization of the BMI (29.7-30.0 after completion; P = 0.287) and a significant reduction in body fat percentage (33.0% to 31.8%; P = 0.049).
Bone Mineral Density
In RTRs, 1 year of home-based aerobic exercise 48 did not influence bone mineral density (BMD) in either the exercisers (0.970-0.995 g/cm 2 at 12 months) compared to the control group (1.012-1.024 g/cm 2 ; P > 0.05). In HTRs, a 6-month weekly lumbar extensor and twiceweekly upper and lower limb resistance training program 71 found that bone demineralization occurred early after transplantation, and BMD losses from compartments with trabecular bone, such as the lumbar spine, were greater than BMD losses from regions with cortical bone, such as the femoral neck. Bone mineral density losses in the lumbar vertebrae were 12% and 15% in the control and training groups, respectively, at 2 months after transplantation. After the intervention, losses were significantly reduced compared to the control group (−3% vs −16%; P < 0.05). The main finding of this study was that resistance training was osteogenic and restored BMD toward pretransplantation levels in HTRs despite continued immunosuppression with glucocorticoids. In contrast, regional BMD in the control group did not indicate any significant recovery toward preoperative levels by 8 months after transplantation. Additionally, a 6-month resistance training program with calcitonin supplementation versus calcitonin alone 72 found that total body BMD did not decrease significantly below pretransplantation values at 2 months after transplantation in either the calcitonin plus training (−0.5%) or calcitonin reference groups (−1.7%). At 8 months after transplantation, both the calcitonin group (−2.4%) and the calcitonin plus training group (−2.6%) experienced small but significant (P < 0.05) losses in total body BMD when compared to pretransplantation values. The magnitude of change in total body BMD at 2 and 8 months after transplantation were comparable in the 2 groups. This suggests that neither calcitonin nor calcitonin plus mechanical loading were efficacious in preventing small long-term reductions of BMD in nonmetabolically active, slow turnover, cortical bone cells of the appendicular skeleton in HTRs.
In LTxRs, before commencing the training study, 73 both the trained (0.63-0.54 g/cm 2 of hydroxyapatite) and control groups (0.62-0.53 g/cm 2 of hydroxyapatite) lost significant and comparable amounts (−14.5%) of BMD between study entry and 2 months after transplantation. After 6 months of weekly lumbar extensor training, the control group lost further lumbar BMD between 2 and 8 months after transplantation (0.53-0.50 g/cm 2 of hydroxyapatite; P < 0.05), decreasing to values that were 19.5% less than pretransplantation baseline. Lumbar BMD in the trained group increased significantly (+9.2%) after 6 months (0.54-0.60 g/cm 2 of hydroxyapatite) and returned to values that were within 5% of pretransplantation baseline. The aforementioned resistance training program, in combination with alendronic acid, led to a bigger improvement than alendronic acid alone. 74 Lumbar BMD decreased significantly to below pretransplant baseline at 2 months after transplantation in controls (−12.5%), but not in the alendronate (1.5%) or alendronate + training (1.5%) groups. At 8 months after transplantation, lumbar BMD in controls was 14.1% below baseline (P < 0.05) but was 1.4% above baseline in alendronate recipients (P > 0.05). The alendronate + training group showed a significantly increased lumbar BMD, with values 10.8% greater than before transplant. This indicates that pharmacological intervention should be prescribed alongside resistance exercise for the greatest benefit in LTxRs.
A 24-week combined resistance and aerobic-based regime based either at home or supervised in a clinical setting for LivTxRs 70 found that total BMD did not change significantly in any group from baseline to after completion of the program (supervised: 1. ). However, proximal femoral BMD did differ significantly in the home-based exercise group compared to the controls (home-based: 0.9-0.8 g/cm 2 ; control: 0.9-0.9 g/cm 2 ; P = 0.017), although there were no differences in T or Z-scores. Similarly, a randomized home-based cardiovascular exercise and dietary education program found no difference in BMD between the exercisers (1.14-1.15 g/cm 2 ) and controls (1.15-1.17 g/cm 2 ).
EXERCISE CAPACITY Muscle Strength and Function
In RTRs, a thrice-weekly strengthening focused exercise program of 6 months duration 75 found that upper-extremities muscle strength increased more in the rehabilitation group (15.99-18.56 after completion) compared to the control group (15.89-16.88) , although this did not reach significance. Similarly, a 7-week isokinetic bicycle-based exercise program investigating outcomes in those on prednisolone compared to those on steroid-sparing regimes 66 found improvements in peak torque (at 60 degrees) in both groups (prednisolonefree: 236-289 Nm after training completion; P < 0.005; prednisolone: 207-237 Nm; P < 0.005) and in total work output (at 180 degrees/second (prednisolone-free: 3563-4584 J after training completion; P < 0.001; prednisolone: 2712-3587 J; P < 0.001). Benefits were also seen in a study of Don Jeon 55 for a duration of 9 weeks with 1 once-a-week supervised session and daily activity at home, where grip strength (P < 0.001), back muscle strength (P = 0.01), and sit-and-reach distance (P < 0.001) all improved in the intervention group compared to those receiving usual care.
In RTRs, 1-year of home aerobic training 48 also resulted in an improvement in peak torque (per body weight) in the intervention group (34.5-42.5 ft/lb/kg) compared to the control group (33.7-37.2 ft/lb/kg; P < 0.003). Furthermore, a study of 24 weeks of treadmill exercise alone 76 revealed that exercise time to exhaustion (12 minutes; P < 0.001) improved, and there were also large increases seen in isokinetic muscle function in both the quadriceps and hamstrings (P < 0.001 to P < 0.0001), although values were still lower than in the untrained nontransplanted healthy control group. Muscle biopsies showed an unexpected rise in type 2 muscle fibres and low oxidative capacity, suggesting that enhanced muscle contractile function is partly responsible for improved overall performance.
In comparison of aerobic training versus resistance training alone in RTRs, 77 12 weeks of twice-weekly supervised exercise found an improvement in the isometric quadriceps muscle force in both of the exercising groups (aerobic: 77.9-81.0 nmol/L after 12 weeks; resistance: 91.2-130.3 nmol/L), whereas the control group actually deteriorated (101.0-95.1 nmol/L), with a significant difference between the resistance-trained group and the controls (P = 0.006) A similar pattern was seen in performance in the sit-to-stand 60 test (aerobic: 24-27 reps; resistance: 30-37 reps; control: 26-26 reps), where improvements were seen in both intervention groups in comparison to the controls, although only the difference between resistance training and controls was significant (P = 0.009).
In HTRs, a 6-month study of cycle-based moderate intensity exercise 5 times a week at home 52 found that in the training group, physical performance improved significantly, with exercise time (7.65-11.40 minutes; P < 0.01) and maximal workload (75 W-105 W; P < 0.01), both improving, and the anaerobic threshold was reached at higher workloads (50-75 W). In the control group, physical performance did not improve with VO 2peak (14.33-15.60 mL/kg per minute), exercise time (8.00-8.50 minutes) and peak workload (70-78 W) remaining comparable to baseline. Another study of 10 weeks of aerobic exercise 2 to 3 times per week 49 found a significant increase in peak HR in the exercising group (128-146 beats per minute) compared to the control group (136-142 beats per minute; P < 0.05) and in duration of the exercise to exhaustion test (exercisers: 9.2-10.7 minutes; control: 8.5-8.8 minutes; P < 0.05).
A 6-month structured aerobic and strength training program designed for HTRs 78 revealed that peak workload increased in the exercisers (59-94 W) compared to the usual care group (66-78 W; P = 0.01) and the duration of exercise performed also improved (exercisers: 6.9-9.0 minutes; controls: 7.2-8.3 minutes; P = 0.07).
A study of either moderate exercise or an HIIT regime of 12 weeks' duration commenced more than 12 months after heart transplant 50 found improvements between groups in workload achieved (HIIT: 148-162 W; moderate: 155-158 W; P = 0.003) and peak HR (HIIT: 139-144 beats per minute; moderate: 140-141 beats per minute; P = 0.027). A second study of HIIT versus usual care 68 also found a significant improvement in peak HR (HIIT: 159-163 beats per minute; Control: 154-153 beats per minute; P = 0.035) as well as the test duration (HIIT: 10.6-14.1 minutes; control:12.2-13.0 minutes; P < 0.001) and quadriceps and hamstring strength (HIIT: 394-402 nmol/L; control: 380-359 nmol/L; P = 0.043).
After LTx, there are significant gains in exercise capacity. In the first 3 months, there is a 60% to 75% increase in the distance covered in 6-minute walking test (6MWT), with an ensuing plateau in performance. 79 However, VO 2max remains deficient compared to expected levels with a function of 40% to 60% of predicted achieved, 80, 81 but there is no overall ventilatory limitation to mild exertion required for daily living. 82 Exercise capacity is reduced in both SLTxRs and DLTxRs. 83 Single lung transplant recipients have similar thigh muscle volumes, intramuscular fat infiltration, and strength of the quadriceps and hamstrings to those with COPD who have not undergone transplantation. However, quadriceps endurance tends to be lower in LTxRs compared to people with COPD. 84 A 12-week study of thrice-weekly cycling 85 found that endurance time was improved in LTxRs to the same extent as healthy subjects but with greater variability between patients (LTxRs: +9 minutes; healthy control: +8 minutes; P < 0.05). Additionally, muscle strength significantly improved in LTxRs, with similar increases also seen in the healthy controls (LTxRs: +4.6 kg; P = 0.001; controls: +3.1 kg; P = 0.047), leading to a recovery of muscle strength as compared with the initial healthy subjects' value. In LTxRs, there were also trends to significant changes in the percentage of type I fibre (+7%, P = 0.10) and the type II fibre diameter (−3 μm, P = 0.10). Three months of supervised combined aerobic and resistance training 54 resulted in an improvement in performance in the 6MWT at 1 year in the LTxRs undergoing exercise training (56% predicted (pred)-86% pred) compared to the controls receiving usual care (51%pred-74%pred; P = 0.002) as well as peak workload (exercisers: 47%pred-69%pred; controls: 39%pred-53%pred; P = 0.043) and quadriceps force (exercisers: 63%pred-92%pred; controls: 56%pred-71%pred; P = 0.001). An early intervention of mixed aerobic and strengthening training 86 initiated in the first few weeks after transplant also reported an improvement in performance in the 6MWT (451 m at 1 month to 543 m at 3 months after transplantation). Improvements between all time points were statistically significant (P < 0.0001), although with no control group for comparison, it is difficult to make assumptions from this study that LTxRs would not have shown improvement after transplantation without the intervention.
In LivTxRs, 10 months of home-based aerobic exercise 69 led to a significant increase in quadriceps strength in the exercising group over time (26.9 ft/lb/weight-32.6 ft/lb/weight; P < 0.001), although this was not significantly different from the control group (29.2 ft/lb/weight-32.9 ft/lb/weight). Additionally, after 24 sessions of aerobic treadmill-based exercise, 87 the exercising group increased their walking distance (baseline: 453.6-582.5 m after the program; P < 0.05) compared to the controls receiving usual care (baseline 516.5-517.7 m). A randomized 24-week combined resistance and aerobicbased regime based either at home or supervised in a clinical setting 70 revealed no significant improvement in performance in the 6MWT between the supervised exercisers (baseline: 506.2 m to after program: 573.3 m), home-based exercisers (491.2-550.5 m) or the control group receiving usual care (530.9-553.6 m; P > 0.05) or in the quadriceps strength (supervised: 506.2-573.3 Nm; home: 491.2-550.5 Nm; control: 530.9-553.6 Nm; P > 0.05). However, a supervised 12-week combined aerobic and strength training program with lifestyle counseling 62 with no control group did find a nonsignificant trend toward improvement in quadriceps strength (baseline: 1.3 Nm/kg; after program: 1.4 Nm/kg; P = 0.058), although improvements in workload (baseline: 1.6 W/kg; after program: 1.7 W/kg; P = 0.004) and performance in the 6MWT (baseline: 546.5 m; after program: 578 m; P = 0.004) were significant.
Cardiorespiratory Fitness
In RTRs, a 6-month strengthening program, 75 discovered that peak expiratory flow rate increased significantly in those undergoing strength training (intervention: 419-516 L/min; control: 439-483 L/min). One year of home aerobic training 48 also resulted in a significant improvement in age-predicted VO 2 (intervention: 70.9% to 85.4% at 1 year; control: 71.6% to 77.4%; P < 0.03), although peak respiratory exchange ratio did not change (intervention: 1.32-1.35; control: 1.38-1.37; P > 0.05). Another study of treadmill exercise alone 76 revealed that exercise time to exhaustion (12 minutes; P < 0.001), VO 2max (37.5 mL/kg per minute; P < 0.05) and maximum ventilation rate (68.5 L/min; P < 0.05) all improved. In comparison of resistance or aerobic training versus standard care, 48 VO 2max increased over time in all groups (aerobic: 12.3-15.1 mL/kg per minute; resistance: 14.1-16.8 mL/kg per minute; control: 11.8-12.8 mL/kg per minute); however, significantly greater gains were seen in those who were trained compared to the control group (aerobic vs control, P = 0.02; resistance vs control, P = 0.002). Nevertheless, in comparison of VO 2max between very well-trained RTRs and nontransplanted controls, the transplant patients still have decreased mechanical efficiency as reflected by an increased VO 2 /treadmill-speed relationship. 88 Observational studies have found that even in well-trained HTRs, there were still deficiencies in VO 2max and treadmill speed and the VO 2max /treadmill speed relationship compared to healthy controls.
88,89 A 6-month study of cycle-based moderate intensity exercise 52 found that in the training group, VO 2peak improved significantly (14.93-19.61 mL/kg per minute; P < 0.001) compared to the control group (14.33-15.60 mL/kg per minute; P < 0.05), and this is supported by a shorter study of 10-week duration of aerobic exercise, 49 where VO 2max also increased to a greater extent in the exercisers (intervention: 16.7-20.0 mL/kg per minute; control: 15.5 16.1 mL/kg per minute; P < 0.05).
After a 6-month combined aerobic and strength training program, 78 it was observed that VO 2peak increased significantly in the intervention group (9.2-13.6 mL/kg per minute) compared to the controls (10.4-12.3 mL/kg per minute; P = 0.01).
High-intensity interval training 50 has been found to be more beneficial in HTRs than moderate aerobic exercise in improving VO 2peak (HIIT: 23.2-28.1 mL/kg per minute; moderate: 23.0-25.6 mL/kg per minute; P < 0.001). However, the respiratory exchange ratio remained unchanged in both the HIIT (1.18-1.15) and moderate groups (1.20-1.18, P = 0.754). These results are supported by another study 68 of 24 weeks of HIIT training, where VO 2peak also improved significantly in those in the intervention group (27.7-30.9 mL/kg per minute) compared to the controls (28.5-28.0 mL/kg per minute; P < 0.001), and the respiratory exchange ratio remains stable (HIIT: 1.07-1.08; control: 1.06-1.07; P = 0.602).
After a 12-week home-based cycling program comparing healthy controls and LTxRs, 90 forced vital capacity (FVC) (LTxRs: 78%pred-82%pred; P = 0.19; controls: 109%pred-109%pred; P = 0.82) and forced expiratory volume in the first second (FEV 1 ) (LTxRs, 74%pred-77%pred; P = 0.44; controls: 108%pred-106%pred; P = 0.20) remained generally stable in both groups. However, VO 2max did show a trend for improvement in the LTxRs (63%pred-68%pred; P = 0.07) and increased significantly in the healthy controls (101%pred-113%pred; P = 0.02). Similarly, a 12-week study of thriceweekly home-based aerobic exercise 85 discovered that VO 2peak was significantly improved in healthy subjects after the program, although there was only a trend to improvement observed in LTxRs (+0.13 ± 0.22, P = 0.059). Additionally, a 6-week part home-based, partly supervised, aerobic training program 91 found a significant improvement in VO 2peak from baseline (18.4 mL/kg per minute) compared to after training (20.3 mL/kg per minute; P < 0.05), although there were no controls for comparison; therefore, it is difficult to conclude that the improvements seen were greater than would have been seen in those receiving usual care.
After a supervised mixed aerobic and strength training program of the same duration, 54 VO 2max showed a nonsignificant improvement compared to the nonexercising controls (exercisers: 55%pred-78%pred; controls: 47%pred-63%pred; P = 0.082) with FEV 1 also being nonsignificant (exercisers: 79%pred-92%pred; controls: 69%pred-89%pred; P = 0.615). A mixed endurance and resistance rehabilitation program (with no control group), 86 completed in the first 12 weeks after lung transplant, found that both FEV 1 and FVC significantly increased after the training program (P < 0.0001). Forced expiratory volume in the first second increased from 71% at 1 month to 78% at 2 months and 81% at 3 months. The improvement from 2 to 3 months was not statistically significant. Forced vital capacity improved from 69% at 1 month to 77% at 2 months and 81% at 3 months, with improvements between each time point being statistically significant.
After LivTx, VO 2peak increases by a modest amount 92 ; however, it actually decreases in one quarter of patients. This persistent impairment of exercise tolerance is principally peripheral in origin, but anemia and beta-blocker treatment should be considered as major aggravating factors. 93 A randomized 10-month home-based aerobic exercise program in combination with dietary advice 69 discovered that age-predicted VO 2peak increased significantly in the exercising group (71.9%pred-90.1%pred) compared to the control group receiving usual care (73.2%pred-83.0%pred; P < 0.04), although the respiratory exchange ratio did not change in either group from baseline to 12-month assessments (intervention: 1.11-1.10; control: 1.12-1.11; P > 0.05). An uncontrolled, supervised 12-week combined aerobic and strength training program with lifestyle counseling 62 also found that VO 2peak increased significantly from baseline (20.9 mL/kg per minute) to after the intervention (22.4 mL/kg per minute; P = 0.031).
QUALITY OF LIFE AND ANXIETY AND DEPRESSION
Health-related quality of life describes the subjective assessment of the impact of disease and its treatment across the physical, psychological, and social domains of functioning and well-being. 94 There are many factors of HRQoL including satisfaction with life and individual happiness, as well as objective assessments of physical and psychological functioning. 95 In research studies involving transplant recipients, the most commonly used method of evaluation of anxiety and depression is the Hospital Anxiety and Depression Scale (HADS). 96 The HADS is a validated screening instrument for the presence of depression and anxiety symptoms, which is widely used in hospital settings, it takes less than 5 minutes to complete, and has been shown to be acceptable by the population for which it was designed. The HADS consists of 14 Likert-scaled items with 2 subscales (0-21). Each subscale includes 7 items scored on a 4-point scale between 0 and 3. Subscale scores of up to 7 are considered normal, whereas scores of 8 to 10 are regarded as borderline and set as clinical manifestation. Both scales can be interpreted independently from each other. Health-related quality of life is most commonly measured using the internationally validated SF-36 questionnaire. 97 Thirty-six items are combined into 8 scales such as physical functioning (PF, 10 items), social functioning (SF, 2 items), role limitations due to physical problems (RP, 4 items), role limitations due to emotional problems (RE, 3 items), mental health (MH, 5 items), energy and vitality (VIT, 4 items), bodily pain (BP, 2 items), and a general perception of health (GH, 5 items). The subscales can be combined into 2 summation scales measuring the overall physical and mental HRQoL (a physical component summary and a mental component summary). Sometimes, shortened versions of this questionnaire can be used when time constraints apply (eg, SF-12 or SF-8).
HRQoL and Anxiety and Depression After Transplantation
Health-related quality of life often does not improve according to expectations, as RTRs have ongoing physical and psychological issues, which persist postoperatively. Diagnoses of psychiatric disorders remain high in RTRs with some studies reporting a prevalence of 50% with affective disorders, major depression, and anxiety being most common at approximately 5 years after transplant 98 and those with a cadaveric transplant are more likely to experience anxiety and depression than those who receive a living transplant. 99 Using the Spielberg State Trait Anxiety Inventory and the Beck Depression Inventory (BDI), anxiety scores are significantly lower among living transplant recipients (80.2) compared to cadaveric transplant recipients (86.9, P = 0.03). There is also a significant relation between depression score and kind of graft donation (living: 11.6; cadaveric: 16.4; P < 0.005). However, HRQoL has been found to improve after renal transplant with a significant improvement in all QoL domains. 100 This improvement occurs within the first 6 months after surgery and remains stable after that. Predictors of QoL include number of hospital admissions (representing early morbidity after transplantation), work (representing economic autonomy), and social support.
After heart transplant, a significant overall improvement in QoL is perceived not only immediately after the operation 101 but also in the long-term. 102 However, another study found that in the immediate post-transplant period, there were no significant differences in adjustment, physical function, and employment between HTRs and similar medically managed heart failure patients. 103 The long-term improvements 102 are apparent in the physical domain, social dimension, and psychological dimension. The improvement remains stable up to 5 years after transplant and is not correlated with age, rejection episodes, preoperative medical parameters, or medication; and this is supported by other studies that have also shown improvements in physical functioning 104, 105 and perceived quality of life 106, 107 in HTRs. In the first 3 years after heart transplant, survival analysis indicates that cumulative risks for disorder onset are major depression, 25.5%; adjustment disorders, 20.8%, posttraumatic stress disorder, 17.0%; and any assessed disorder, 38.3%, with only one case of generalized anxiety disorder. 108 Posttraumatic stress disorder onset is limited almost exclusively to the first year after transplantation. Episodes of major depression (but not anxiety disorders) that occur at 8 to 36 months after transplant are more likely than early posttransplant episodes to be treated with psychotropic medications. Factors increasing cumulative risk for posttransplant psychiatric disorder include a pretransplant psychiatric diagnosis, female sex, longer hospitalization, more impaired physical functional status, and lower social supports from caregivers or family in the perioperative period. At approximately 10 years after transplantation moderate or severe depression is still experienced by approximately 37% of patients, 109 although interestingly, approximately 50% report good or very good satisfaction with QoL and physical health. However, the prevalence of depression is negatively associated with physical domain (r = −0.45, P < 0.01), social domain (r = −0.49, P < 0.05), and psychological domain (r = −0.3, P < 0.05). The worst QoL signifies a high prevalence of depression, and the subjective assessment of QoL negatively correlates with the prevalence of depression (r = −0.43; P < 0.01).
Within the first 2 years after lung transplantation, 110 LTxRs report that several symptoms are both frequently occurring and rather distressing such as muscle weakness (occurs in 40%, distressing in 46%), shortness of breath with activity (occurs in 32%, distressing in 36%), and increased hair growth (occurs in 54%, distressing in 29%). At approximately 5 years after lung transplant, patients demonstrate statistically lower rates of respiratory problems as compared with reference values for patients with COPD. 111 After completion of the SF-36, in the subscales of vitality and mental health and the mental component summary scale, LTxRs had scores similar to those of the healthy control population, although the remaining scores were significantly lower. Additionally, there were no significant differences between the LTxRs and the reported reference healthy population on the anxiety and depression subscales. However, 10% of the patients showed clinical depression and 12% had clinical anxiety.
Levels of anxiety are higher in those waiting for transplant than in the LivTxR group (7.1 vs 5.6; P < 0.05), 112 and the mean score for the depression scale is higher in the waiting group as well (6.5 vs 4.9; P < 0.05). Comparing both groups with data from the reference population (mean scores: anxiety, 4.7; depression, 5.1; total score, 9.9) reveals significant differences for anxiety (P < 0.001), depression (P < 0.05), and the summation score (P < 0.001). There are also significantly higher scores for anxiety (P < 0.001), depression (P < 0.05), and HADS total score (P < 0.001) in the group of patients on the waiting list compared to the reference population. However, after liver transplant, anxiety scores are significantly higher (P < 0.001).
Before liver transplantation, half of patients report some level of distress in 14 of 21 HRQoL determinants, whereas 1 year postoperatively, they report distress in only 10 of 21. 113 The most commonly reported symptoms causing distress at baseline are fatigue and muscle weakness, which are experienced by 98% and 90%, respectively; however, these are statistically likely to improve at 1 year, although 86% remain distressed by fatigue and 79% by weakness demonstrating that these continue to be a substantial problem for these patients. At baseline, the Index of Wellbeing is 8.4, and this increases to 11.2 at follow-up, which is similar to that of the general population (11.8) . Although well-being generally improves, it does actually decrease after transplantation in approximately 15% of patients.
Exercise and HRQoL and Anxiety and Depression
One study of active RTRs showed that regular exercise significantly improves different aspects of HRQoL such as social function, general health perception, and mental health, compared to their sedentary counterparts. 114 Additionally, only 2 hours of exercise per week significantly ameliorates RTRs' self-reported health and fitness condition. The amount of exercise participation also positively correlates to the patient's health and fitness condition with no effect on graft function. 115 In RTRs, 10 weeks of thrice-weekly cycling has been shown to improve anxiety (HADS score: baseline, 9.9; after program, 6.0; P < 0.004) and depression (HADS score: baseline, 8.3; after program, 5.9; P < 0.008) scores in RTRs 116 as well as overall HRQoL as measured by the SF-36 questionnaire (baseline: 394; after program: 553; P < 0.0001), although the authors did not provide a breakdown of the scoring for each component. A 9-week intervention of Don Jeon, with 1 once-a-week supervised session and daily activity at home 55 found reductions in both stress (P = 0.03) and uncertainty (P = 0.001) compared to the control group and improvements in self-esteem (P < 0.001) and overall QoL (P = 0.001), although they do not report which questionnaires have been used.
After 1 year of home-based aerobic exercise, 48 the only scale on the SF-36 questionnaire that approached significant differences between the 2 groups was the physical functioning scale (baseline exercisers: 68.1; control: 64.1; 12 months: exercisers: 84.8; control: 73.2; P = 0.06). Although both groups improved in the role physical during the 12 months (baseline exercisers: 39.0; control: 54.9; 12 months: exercisers: 59.4; control: 60.6), it remained low compared with the general population (average for general population is 83). Both groups improved with time in the physical component summary during the 12 months (baseline exercisers: 40.1; control: 40.8; 12 months: exercisers: 47.0; control: 44.8; P < 0.0001), but there were no significant differences between the groups as a function of time. At 12 months, both groups were similar to the general population scores for mental health and the mental component summary; all other scale scores remained lower than the scores reported for the general population.
A 1-year resistance training intervention for 1 hour twicea-week, with psychological and dietary support, specifically designed for obese RTRs, 117 found that the mean SF-36 score at 6 months was significantly higher in the intervention group compared with the control group (583 vs 436; P = .008) and the exercisers had improvements in the domains of vitality (intervention, 53-62; control, 59-25; P < 0.05) and general health (intervention, 39-50; control, 45-29; P < 0.05) compared to the controls receiving usual care. This translated positively into job prospects, as overall, at 12 months, there was a significantly higher employment rate of 77.7% in the exercise group, compared with 12.5% in the control group (P = 0.02).
Heart transplant recipients who participated in an early posttransplant rehabilitation program of supervised cycling or treadmill-walking for 12 weeks showed a significant increase of SF-36 scores in physical functioning (59.7-77. 1-73.4) . 118 This study compared the results to patients undergoing coronary artery bypass grafting and found that after early postoperative cardiac rehabilitation HTRs showed greater improvement in HRQoL than patients with coronary artery bypass grafting regardless of lower physical capacity.
Additionally, a hospital-based exercise program of combined aerobic and strength training 3 times a week over an 8-week period produced a significant improvement in all aspects of the SF-36 questionnaire except for mental health, 119 although there was a significant improvement in depressive symptoms as measured by the BDI (7.36-5.86; P < 0.05). However, there was no change in symptoms of anxiety as recorded on the Spielberger State-Trait Anxiety Inventory (43.89-45.58; P > 0.05).
A 24-week HIIT program for HTRs 68 found that both groups had high HRQoL scores, and there were no significant changes in any of the sum scores. However, there was a significant difference between the exercisers and the control group on the SF-36 General Health subscale at follow-up (exercisers, 54; control, 49; P < 0.05). As for subjectively improved health, the exercisers reported 65 on the visual analog scale compared to 26 in the control group (P < 0.001).
A 12-week home-based aerobic training program after lung transplantation 85 improved symptoms of dyspnea (3.6-4.2 after training, P = 0.03), and a there was an observed trend toward decreased fatigue (4.5-4.8, P = 0.07) as measured by the chronic respiratory questionnaire.
A program for LTxRs within the first 12 weeks after transplantation, of mixed aerobic and strengthening training, 86 revealed that all HRQoL domains improved from month 1 to 3 when measured using the SF-36. Physical conditioning demonstrated gains up to 3 months (physical functioning: 46 at baseline to 75 at 3 months; P < 0.05; role functioning physical: 31-71; P < 0.05), whereas symptoms related to surgery, for example, pain (39 at baseline to 62 at 2 months to 66 at 3 months), showed a reduction up to 2 months (P < 0.05) and then this effect plateaued.
A 3-to 4-week inpatient intensive rehabilitation program of aerobic and strengthening training for LTxRs approximately 4.5 years after transplantation 120 found no significant improvements in HRQoL (SF-36) could be demonstrated in either the exercise group or the usual care group. In fact, the groups were found to have an already good HRQoL at the first evaluation visit, as indicated by SF-36 scores greater than 80% of 100% best possible and, although there was a slight trend toward increased HRQoL levels, this did not reach statistical significance.
A RCT of 3 months of 3 times-a-week combined aerobic and resistance training 54 only found a significant improvement in the physical components of the SF-36 when the intervention group was compared with controls (physical functioning: intervention, 43 at baseline to 77 after 1 year; control, 36-65; P = 0.039. Role functioning physical: intervention, 31-83; control, 22-52; P = 0.011).
More physically active LivTxRs have improved general health, physical function, bodily pain, and vitality. 121 Fatigue is a common problem after LivTx, 122 with 60% perceiving themselves to be fatigued or severely fatigued. After an uncontrolled twice-a-week, 12-week aerobic and strength rehabilitation program, LivTxRs reported an increase in health-related daily functioning (Sickness Impact Profile-68, 10.39-7.94; P = 0.007). When assessing HRQoL with the SF-36, only physical functioning (67.5-75.3; P = 0.007) and vitality (7.8-58.1; P = 0.019) were statistically significant, and the HADS score did not improve for either anxiety (5.5-5.4; P = 0.929) or depression (5.8-5.4; P = 0.432). Furthermore, another uncontrolled, supervised 12-week combined aerobic and strength training program with lifestyle counseling 62 found that there was a clinically relevant improvement in fatigue after the intervention (Fatigue Severity Scale, 5.5-4.9; P = 0.014; visual analog scale, 63.5-50.3; P = 0.043; and Checklist Individual Strength, 38.5-28.0; P = 0.007).
A randomized 10-month home-based aerobic exercise program in combination with dietary advice 69 found that only the general health aspect of HRQoL improved (SF-36 intervention, 54.5-65.1; control, 58.8-63.0; P < 0.05). This indicates that the increase in general health over time is greater for the exercisers than for those receiving usual care. All other physical scales increased in both groups (P < 0.05), but the change was not significantly different between the exercisers and the controls. Of the mental scales, only mental health showed a significant group-by-time interaction (exercisers, 78.5-83.4; control, 79.3-77.9; P = 0.009), with the increase being greater over time in the exercising group. Vitality and social functioning increased in both groups (P < 0.001) at 12 months.
SPORTING PERFORMANCE AFTER TRANSPLANTATION
Renal Transplant
High-intensity exercise and sport have not been extensively investigated in transplant recipients, with most publications being case report or small-scale studies.
A study of RTRs, performed at the WTG, 123 determined that the mean energy expenditure was 3376 ± 739 kcal/d, corresponding to 43.7 ± 13.6 kcal/kg per day, which is 25% higher than those of age-matched inactive healthy subjects. The transplant recipients were also able to perform activity at an intensity level greater than 3 times the resting MET for 197 ± 112 minutes, suggesting that SOTRs are capable of taking part in sustained moderate to vigorous activity. However, the RTRs did perform at a lower level compared to age-matched best performances of nationally competitive healthy athletes. After a complicated posttransplant recovery, a previously competitive swimmer has managed to complete a successful rehabilitation program and return to swimming, 124 taking part in several WTG and gaining many medals and records. Although transplant patients are performing at a lower level than healthy athletes, with a structured training program, there is potential for them to return to performance levels that match their nontransplant counterparts with adequate training, motivation, and nutrition. Another example of a RTR returning to competition with nontransplant athletes is seen in a case study of a professional boxer. 125 Within 3 years of transplantation, he had returned to regular training and commenced protein supplements to improve his body composition. Despite recommendations from physicians, he continued to box professionally and has had no adverse effects to his graft function.
Heart Transplant
A patient who developed cardiac failure owing to dilated cardiomyopathy underwent a cardiac transplant, 126 and as part of his rehabilitation, he was introduced to tennis. At 22 months after transplant, he was able to match the aerobic capacity of an age-matched member of the general population. He went on to participate successfully at the WTG and has managed to maintain his physiological function a decade later at his most recent assessments. Furthermore, an elite cyclist who experienced heart failure after a myocardial infarction received a heart transplant 4 months later. 127, 128 He resumed training after 1 month and underwent maximal exercise testing. Before his myocardial infarction, his VO 2max was 58 mL/kg per minute, this remained reduced at both 6 and 12 months after transplant, although there were significant improvements over time. These results imply that if an individual is physically fit before their transplant, then this may positively affect their subsequent work capacity. In active HTRs, it may be beneficial to introduce a more intensive rehabilitation program so that they can return to competition faster.
It is difficult to predict which patient's chronotropic incompetence will affect. A young HTR experienced a severely reduced exercise capacity with a workload of only 56% predicted, 129 with the major contributor being an insufficient HR response to activity. She had a pacemaker implanted, and this significantly improved her physical performance, resulting in her winning several medals at the European Heart and Lung Transplant Games. This demonstrates that chronotropic incompetence can be successfully treated, and it does not necessarily limit subsequent athletic performance.
Further case reports have shown that after an intensive endurance training program, HTRs are able to improve maximal power, oxygen consumption, resting and submaximal HR, and ventilator anaerobic threshold. One such report featured an HTR who completed the Boston marathon in less than 6 hours with no observed complications, 130 and the second successfully competing for an intercollegiate conference championship soccer team. 131 Additionally, in endurancetrained HTRs, 132 graded exercise does not alter levels of malondialdehyde in either HTRs or healthy controls, and there is also no difference in glutathione peroxidase activity or vitamin E levels, suggesting that exercise to fatigue does not promote an increase in oxidative stress in the blood of HTRs.
Heart and Lung Transplant
A patient with cystic fibrosis successfully underwent a HLTx. 133 One year after surgery, exercise capacity was slightly reduced owing to cardiocirculatory rather than ventilatory limitations. In the 10 years after transplantation, he took part in strenuous training to compete in sports events for transplant patients. Exercise testing revealed better-than-normal aerobic and ventilatory capacity as characterized by a noticeably high oxygen uptake, oxygen pulse, and delayed onset of ventilatory anaerobic threshold. This suggests that patients who have had a HLTx are capable of achieving high levels of physical fitness and can perform well in competitive environments. Therefore, those patients who are motivated to return to intense physical activity should be encouraged, as their maximal physical capabilities are often not reached by conventional rehabilitation.
Sporting Performance in an Extreme Environment
Performance in an extreme environment has been assessed by studying RTRs while trekking in the desert. 134 There were minimal differences between transplant and healthy-controls for BP, hydration status, walking velocity, and intensity of physical activity. The selected transplant patients, who had a creatinine clearance greater than 55 mL/min, showed a nearnormal physical performance and acclimatization to the extreme conditions of the desert environment, which suggests that performance of RTRs can be maintained even in challenging environmental conditions. Moreover, 6 LivTxRs and 15 healthy controls participated in a trek up Mount Kilimanjaro in Tanzania, with an ascent of 5895 m. 135 Most of the participants successfully completed the trek (83% LivTxRs vs 84.6% controls). Of those who were unable to complete the climb, the LivTxR reported physical exhaustion and the 2 controls developed gastroenteritis and cerebral edema, respectively. Overall, there was no difference in physical performance, perceived exertion, or altitude sickness between groups. However, both experienced reduced oxygen saturations and a rise in BP and HR as altitude increased. The only significant difference was the development of hypertension in LivTxRs at 3950 m. This study provides evidence that LivTxRs can safely participate in strenuous physical activity at high altitude, as their adaptive responses are similar to the control participants with few adverse events seen.
Additional information on the studies can be found in Table 1 .
RISKS OF EXERCISE AND SPORT
There are risks to the transplant recipients of a return to sport, although documented adverse events are mostly linked to traumatic events. One RTR developed a traumatic lymphocele after direct trauma from a squash ball 136 requiring marsupialization of the lymphocele in the peritoneal cavity, although the patient recovered fully despite being very unwell initially. Additionally, after intense gym sessions and heavy lifting, a RTR reported anuria. 137 Investigations revealed a hematoma secondary to a spontaneous pseudocapsular bleed or intense activity. After evacuation of the blood clots in theater, the patient began to pass urine and has made a full recovery.
Infection remains a concern in transplant recipients, and, as exercise can be detrimental to the immune system, it should be considered when athletes who are already immunosuppressed are training intensely. 138 After cycling in an 81-km event, 10 RTRs and 10 healthy controls underwent simulated exposure to pathogens. 139 Analysis revealed an oppositional pattern of gene expression in RTRs compared to controls. In addition, in RTRs, several apoptotic genes were overrepresented, whereas immune response genes were seen more commonly in controls. Renal transplant recipients also had a significantly lower relative increase in neutrophils after the bout of exhaustive exercise. 140 In HTRs, one study discovered that lymphocyte subpopulations do not change during or after a 6-week cycling exercise intervention, 141 with only slight, nonsignificant, increases in total T cells, activated T cells, cytotoxic T cells, and the T4+/T8+ ratio. Additionally, levels of immunosuppression in the /Ohm in C subjects) in both groups. Mean heart rate did not differ between T (135 ± 10 bpm) and C (136 ± 5 bpm) subjects throughout the study, although a reduction from day 1 to day 5 was observed in T subjects only (P < 0.05 vs C group). No differences were found between T and C group in walking velocity (1.7 ± 0.6 km/h in T and bloodstream, and episodes of rejection and infections are also unaffected. Another supervised 8-week aerobic program found that there is no effect on plasma markers of inflammation (C-reactive protein, IL-6, tumor necrosis factor α). 142 However, the control group (HTRs receiving usual care) did have a significant rise in tumor necrosis factor α after completion, suggesting that activity does have a role in improving inflammation in HTRs.
Many individuals who receive a SOT regard it as an opportunity to embark on a new healthier lifestyle or to re-engage with sporting activities they enjoyed before their transplant. There are many opportunities for SOTRs to partake in competitive sporting events, and they are often able to achieve a fitness level near to that of the general population. Although the intensive training and exercise that they participate in is usually well-tolerated, there are potential issues that may arise, and therefore, the benefits of exercise cannot simply be considered as for the general population. The effects of immunosuppression and the known increase in CV risk means that undertaking physical training may result in abnormal responses of the immune and CV systems to exercise. Given the paucity of research, and that it has been highlighted as a top research priority by a panel of transplantation and sports experts, 143 further studies need to be conducted, so that evidence-based guidelines can be produced for this complex population, ensuring the best possible outcomes while limiting adverse events.
CONCLUSIONS AND RECOMMENDATIONS
This review explores the benefits of structured exercise programs on the health of SOTRs. Incorporation of exercise into the routine postoperative care of transplant recipients should be strongly considered owing to the improvement in many aspects of well-being in these patients and the absence of significant complications or adverse effects.
Cardiovascular System
Exercise programs of combined aerobic and strength training of at least 3 months' duration seem to be most effective at reducing BP in HTRs and LTxRs, with HIIT being a promising alternative. However, RTRs seem to gain less benefit, and this may be in part due to their underlying disease process and suboptimal renal function. Cholesterol and triglyceride levels do not seem to be augmented by exercise, with transplant recipients experiencing increases over time regardless of activity. Liver transplant recipients who are more likely to experience metabolic syndrome did, however, have static total cholesterol:HDL cholesterol after training, and this may represent a slowing of the progression of hypercholesterolemia. Glycemic control in RTRs is improved by a 6-month combined lifestyle education and endurance exercise program and LTxRs achieve benefit after 3 months of combined training. However, LivTxRs experience worsening of glycemic control despite 12 weeks of exercise, and this again reflects the complexities of treating those with increased risk of metabolic syndrome; LivTxRs may benefit from longer interventions or modification of the training program to include dietary and lifestyle advice.
Body Composition
Both aerobic and combined resistance and aerobic training programs of at least 12 weeks' duration are effective in increasing lean muscle mass; however, there are few improvements seen in fat mass and overall body weight and BMI. Even when dietary advice has been incorporated into the programs, there have been no additional benefits observed. Bone mineral density decreases in transplant recipients postoperatively, predominantly owing to immunosuppression and steroids, and this decline is reduced by targeted lumbar resistance training of at least 6 months' duration. The greatest benefit is seen when combined with alendronic acid, although calcitonin supplementation is not effective. Results have been less promising in improving femoral BMD and also in LivTxRs, and this requires further investigation.
Exercise Capacity
Interventions comprising of aerobic or combined aerobic and resistance exercise have consistently been shown to improve workload and muscle strength. Durations of between 12 weeks and 12 months and both home-based and supervised training have been effective in all types of transplant recipient. These improvements are also translated into a significant improvement in physical performance in a variety of tests such as the 6MWT and the capacity to exercise until exhaustion.
In RTRs, HTRs, and LivTxRs, aerobic, resistance, or combined training leads to consistent gains in aerobic capacity, with improvements being seen in home-based and supervised programs and also in durations of between 10 weeks and 1 year, with frequencies of between 2 and 5 times a week. However, LTxRs generally see minimal improvement in FVC, FEV 1 , and VO 2max in comparison to transplant recipients receiving usual care in studies of 12 weeks' duration, irrespective of supervision. This is a reflection of their underlying disease status, and they may require longer interventions to see a benefit. In HTRs, HIIT is more effective than moderate continuous exercise in improving exercise capacity, and this could be a potential area of further investigation in other transplant recipients, particularly LTxRs.
Quality of Life
The most commonly used measures of HRQoL and anxiety and depression are the SF-36 and HADS, respectively. In general, there is an improvement in the overall SF-36 score and, in particular, physical functioning, vitality, and general health in all types of transplant recipients, with changes being seen after supervised, inpatient, and home-based exercise of varying types. Measures of mental health prove more variable, with no clear trend emerging with regard to which type of exercise intervention is most beneficial. Similarly, when anxiety and depression are assessed, a short 10-week program of cycling for RTRs significantly improved both anxiety and depression, whereas an 8-week combined program for HTRs showed only a statistically significant improvement in depressive symptoms and in LivTxRs. Twelve weeks of aerobic and strength training failed to show an improvement in either anxiety or depression. Structured exercise programs may be useful in improving anxiety and depression, and more importantly, they are not detrimental to mental health.
